BR0113328A - Molécula de cintilador, processo para a preparação da mesma, lipossoma, micela, métodos para inserir uma ou mais moléculas de cintilador em um lipossoma e em uma célula, célula, kit, sistema de ensaio, composição, kit, e, uso de uma molécula de cintilador - Google Patents

Molécula de cintilador, processo para a preparação da mesma, lipossoma, micela, métodos para inserir uma ou mais moléculas de cintilador em um lipossoma e em uma célula, célula, kit, sistema de ensaio, composição, kit, e, uso de uma molécula de cintilador

Info

Publication number
BR0113328A
BR0113328A BR0113328-4A BR0113328A BR0113328A BR 0113328 A BR0113328 A BR 0113328A BR 0113328 A BR0113328 A BR 0113328A BR 0113328 A BR0113328 A BR 0113328A
Authority
BR
Brazil
Prior art keywords
scintillator
cell
kit
molecule
liposome
Prior art date
Application number
BR0113328-4A
Other languages
English (en)
Portuguese (pt)
Inventor
Roland Zbignieiw Kozlowski
Jonathan Michael Blackburn
John David Sutherland
Steven John Culliford
Andrew James Sutherland
Original Assignee
Procognia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0020503A external-priority patent/GB0020503D0/en
Application filed by Procognia Ltd filed Critical Procognia Ltd
Publication of BR0113328A publication Critical patent/BR0113328A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Materials Engineering (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
BR0113328-4A 2000-08-18 2001-08-17 Molécula de cintilador, processo para a preparação da mesma, lipossoma, micela, métodos para inserir uma ou mais moléculas de cintilador em um lipossoma e em uma célula, célula, kit, sistema de ensaio, composição, kit, e, uso de uma molécula de cintilador BR0113328A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0020503A GB0020503D0 (en) 2000-08-18 2000-08-18 Compounds
US24799400P 2000-11-14 2000-11-14
PCT/GB2001/003695 WO2002014290A1 (en) 2000-08-18 2001-08-17 Lipo- or amphiphilic scintillators and their use in assays

Publications (1)

Publication Number Publication Date
BR0113328A true BR0113328A (pt) 2003-07-29

Family

ID=26244864

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0113328-4A BR0113328A (pt) 2000-08-18 2001-08-17 Molécula de cintilador, processo para a preparação da mesma, lipossoma, micela, métodos para inserir uma ou mais moléculas de cintilador em um lipossoma e em uma célula, célula, kit, sistema de ensaio, composição, kit, e, uso de uma molécula de cintilador

Country Status (10)

Country Link
EP (1) EP1315707A1 (zh)
JP (1) JP2004506754A (zh)
KR (1) KR20030066601A (zh)
CN (1) CN1458925A (zh)
AU (1) AU2001278633A1 (zh)
BR (1) BR0113328A (zh)
CA (1) CA2420006A1 (zh)
GB (1) GB2383329A (zh)
IL (1) IL154485A0 (zh)
WO (1) WO2002014290A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7553559B2 (en) * 2005-12-21 2009-06-30 Lg Display Co., Ltd. Hexatriene derivatives for use as blue emitting materials for organic electroluminescent devices
EP1892530A1 (en) * 2006-08-25 2008-02-27 Boehringer Ingelheim Pharma GmbH & Co. KG Method for determining transport activity of a transport protein
CN104327005B (zh) * 2014-10-21 2016-08-24 华烁科技股份有限公司 2,5-二苯基噁唑的制备方法
JP2022512762A (ja) * 2018-10-21 2022-02-07 ザ ユニバーシティ オブ カンザス 治療用送達プラットフォームを生成するための方法
KR102288775B1 (ko) * 2019-03-26 2021-08-12 동국대학교 산학협력단 신틸레이터 조성물 및 이를 이용하는 신틸레이터
WO2020197032A1 (ko) * 2019-03-26 2020-10-01 동국대학교 산학협력단 신틸레이터 조성물 및 이를 이용하는 신틸레이터

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63227576A (ja) * 1987-03-13 1988-09-21 Hamamatsu Photonics Kk ジフエニルオキサゾ−ル誘導体とその製造方法およびその利用方法
GB2342350A (en) * 1998-10-05 2000-04-12 Univ Nottingham Trent Solid supports containing oxazole scintillants

Also Published As

Publication number Publication date
JP2004506754A (ja) 2004-03-04
EP1315707A1 (en) 2003-06-04
IL154485A0 (en) 2003-09-17
CA2420006A1 (en) 2002-02-21
AU2001278633A1 (en) 2002-02-25
KR20030066601A (ko) 2003-08-09
WO2002014290A1 (en) 2002-02-21
GB0306216D0 (en) 2003-04-23
CN1458925A (zh) 2003-11-26
GB2383329A (en) 2003-06-25

Similar Documents

Publication Publication Date Title
Cullis et al. Physical properties and functional roles of lipids in membranes
Lars Durable proteo-hybrid vesicles for the extended functional lifetime of membrane proteins in bionanotechnology
Rapaport et al. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus‐cell fusion: an emerging similarity with functional domains of other viruses.
Philippot et al. A very mild method allowing the encapsulation of very high amounts of macromolecules into very large (1000 nm) unilamellar liposomes
Nam et al. Giant phospholipid/block copolymer hybrid vesicles: Mixing behavior and domain formation
Sunamoto et al. Naturally occurring polysaccharide derivatives which behave as an artificial cell wall on an artificial cell liposome
Houdai et al. Hairpin conformation of amphidinols possibly accounting for potent membrane permeabilizing activities
BR0010171A (pt) Material composto e membrana composta
Florence Surface chemical and micellar properties of drugs in solution
Hincha et al. The lytic activity of the bee venom peptide melittin is strongly reduced by the presence of negatively charged phospholipids or chloroplast galactolipids in the membranes of phosphatidylcholine large unilamellar vesicles
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BR0113328A (pt) Molécula de cintilador, processo para a preparação da mesma, lipossoma, micela, métodos para inserir uma ou mais moléculas de cintilador em um lipossoma e em uma célula, célula, kit, sistema de ensaio, composição, kit, e, uso de uma molécula de cintilador
NO923703D0 (no) Syntetisk membran vesica som inneholder funksjonelt aktive fusjonspeptider som avgivelsesystem for legemidler
CN105983102A (zh) 基于小核酸药物的破骨细胞靶向递送系统及其制备方法
Lehtonen et al. Binding of daidzein to liposomes
WO2001008707A3 (de) Konjugate und verfahren zu deren herstellung sowie deren verwendung zum transport von molekülen über biologische membranen
AR021604A1 (es) Reactivos lipidizantes sensibles al ph acuosos reversibles, composiciones y metodos de uso
Nagawa et al. Surfactant-induced release from phosphatidylcholine vesicles. Regulation of rupture and leakage pathways by membrane packing
BR9807729A (pt) Sistemas de géis de nimesulida para o uso tópico
ES2067544T3 (es) Membranas de afinidad que tienen grupos hidroxilo pendientes y procesos para la preparacion y uso de las mismas.
ES2078510T3 (es) Dispersion acuosa de vesiculas de fosfolipidos, procedimiento para su fabricacion y su uso.
Wrigglesworth et al. Dynamics of proteoliposome formation. Intermediate states during detergent dialysis
Marques et al. Sequence-specific binding of DNA to liposomes containing di-alkyl peptide nucleic acid (PNA) amphiphiles
Wright et al. Partitioning of teniposide into membranes and the role of lipid composition
Domenech et al. Atomic force microscopy characterization of supported planar bilayers that mimic the mitochondrial inner membrane

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]